Gene therapies to treat rheumatoid arthritis have evolved slowly, but one is ready to move into human trials and an ...

Financial writer recommends Crispr Therapeutics AG as a strong buy due to cash position, drug pipeline, and promising ...

By creating gene editors not found in nature, or optimizing existing editors, AI can improve the accuracy, effectiveness, and accessibility of gene editing.

The most complex engineering of human cell lines ever has been achieved by scientists, revealing that our genomes are more ...

Scientists have successfully engineered the most complicated human cell lines ever indicating that our genomes are more tolerant to significant structural alte ...

Whether you are a beginner or an experienced signer, it's good to understand the different aspects of the language. This includes the basic signs and techniques, where you can find resources to learn ...

CRISPR Therapeutics' lone approved product has billion-dollar potential, while its pipeline also looks exciting. Amgen can make waves in the weight loss market, as well as others, thanks to a ...

CRISPR Therapeutics' stock decline is likely influenced by Editas Medicine's struggles, but CRISPR remains a distinct and stronger company with a promising long-term outlook. CRISPR's strategic ...